Literature DB >> 33664970

Initial symptoms and diagnostic delay in children with brain tumors at a single institution in Japan.

Yuji Yamada1, Daiki Kobayashi2, Keita Terashima1, Chikako Kiyotani1, Ryuji Sasaki3, Nobuaki Michihata2, Toru Kobayashi4, Hideki Ogiwara5, Kimikazu Matsumoto1, Akira Ishiguro2.   

Abstract

BACKGROUND: A prolonged interval between onset of symptoms and diagnosis of childhood brain tumor is associated with worse neurological outcomes. The objectives of this study are to determine factors contributing to diagnostic delay and to find an interventional focus for further reduction in the interval between symptom onset and diagnosis in Japan.
METHODS: We retrospectively analyzed 154 patients younger than 18 years with newly diagnosed brain tumors who visited our institution from January 2002 to March 2013.
RESULTS: The median age at diagnosis was 6.2 years and the median total diagnostic interval (TDI) was 30 days. Patients with low-grade tumors and cerebral midline tumor location had significantly long TDI. Durations between the first medical consultation and diagnosis (diagnostic interval, DI) were exceedingly longer for patients with visual, hearing, or smelling abnormalities as the first symptom (median, 303 days). TDI and DI of patients who visited ophthalmologists or otolaryngologist for the first medical consultation were significantly longer. Among these patients, longer DI was associated with worse visual outcome.
CONCLUSION: Raising awareness of brain tumor diagnosis among ophthalmologists and otolaryngologists may reduce diagnostic delay and may improve the neurological impairment of children with brain tumors in Japan.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  brain tumor; children; diagnostic delay; initial symptom; visual, hearing, and smelling abnormalities

Year:  2020        PMID: 33664970      PMCID: PMC7906264          DOI: 10.1093/nop/npaa062

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN: 2054-2577


  19 in total

1.  Diagnostic delay and morbidity of central nervous system tumors in children and young adults: a pediatric hospital experience.

Authors:  Vanisha Patel; Neil L McNinch; Sarah Rush
Journal:  J Neurooncol       Date:  2019-03-30       Impact factor: 4.130

Review 2.  Pediatric Brain Tumors: An Update.

Authors:  Devorah Segal; Matthias A Karajannis
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2016-05-24

Review 3.  The diagnosis of brain tumours in children: a guideline to assist healthcare professionals in the assessment of children who may have a brain tumour.

Authors:  Sophie Wilne; Karin Koller; Jacqueline Collier; Colin Kennedy; Richard Grundy; David Walker
Journal:  Arch Dis Child       Date:  2010-04-06       Impact factor: 3.791

4.  Duration between onset and diagnosis in central nervous system tumors: impact on prognosis and functional outcome.

Authors:  Kohei Fukuoka; Takaaki Yanagisawa; Tomonari Suzuki; Mitsuaki Shirahata; Jun-Ichi Adachi; Kazuhiko Mishima; Takamitsu Fujimaki; Masao Matsutani; Ryo Nishikawa
Journal:  Pediatr Int       Date:  2014-11-10       Impact factor: 1.524

5.  Health and persistent functional late effects in adult survivors of childhood CNS tumours: a population-based cohort study.

Authors:  K K Boman; E Hovén; M Anclair; B Lannering; G Gustafsson
Journal:  Eur J Cancer       Date:  2009-07-16       Impact factor: 9.162

6.  Delay in the diagnosis of paediatric brain tumours.

Authors:  Milana Dobrovoljac; Heinz Hengartner; Eugen Boltshauser; Michael A Grotzer
Journal:  Eur J Pediatr       Date:  2002-11-08       Impact factor: 3.183

7.  A new clinical guideline from the Royal College of Paediatrics and Child Health with a national awareness campaign accelerates brain tumor diagnosis in UK children--"HeadSmart: Be Brain Tumour Aware".

Authors: 
Journal:  Neuro Oncol       Date:  2015-11-01       Impact factor: 12.300

8.  The Aarhus statement: improving design and reporting of studies on early cancer diagnosis.

Authors:  D Weller; P Vedsted; G Rubin; F M Walter; J Emery; S Scott; C Campbell; R S Andersen; W Hamilton; F Olesen; P Rose; S Nafees; E van Rijswijk; S Hiom; C Muth; M Beyer; R D Neal
Journal:  Br J Cancer       Date:  2012-03-13       Impact factor: 7.640

9.  Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010).

Authors:  Kayo Nakata; Yuri Ito; Winnie Magadi; Audrey Bonaventure; Charles A Stiller; Kota Katanoda; Tomohiro Matsuda; Isao Miyashiro; Kathy Pritchard-Jones; Bernard Rachet
Journal:  Cancer Sci       Date:  2017-12-26       Impact factor: 6.716

10.  Childhood, adolescent and young adult cancer incidence in Japan in 2009-2011.

Authors:  Kota Katanoda; Akiko Shibata; Tomohiro Matsuda; Megumi Hori; Kayo Nakata; Yoshitaka Narita; Chitose Ogawa; Wataru Munakata; Akira Kawai; Hiroshi Nishimoto
Journal:  Jpn J Clin Oncol       Date:  2017-08-01       Impact factor: 3.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.